Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Moosmann

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Cell Reports Methods|June 24, 2025
Characterization of human CMV-specific CD8<sup>+</sup> T cells using multi-layer single-cell omicsIoanna Gemünd, Lorenzo Bonaguro, Matthias Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2016
Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cellsManuel Albanese, Takanobu Tagawa, Mickaël Bouvet, et al.
Journal of Translational Medicine|May 11, 2018
Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell graftsRegina Gary, Michael Aigner, Stephanie Moi, et al.
The Journal of Experimental Medicine|September 14, 2016
Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processingTakanobu Tagawa, Manuel Albanese, Mickaël Bouvet, et al.
European Journal of Immunology|May 26, 2005
HLA type-independent generation of antigen-specific T cells for adoptive immunotherapyMarkus H Hammer, Sonja Meyer, Gordon Brestrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2020
Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cellsM Zeeshan Chaudhry, Rosaely Casalegno-Garduno, Katarzyna M Sitnik, et al.
Blood|January 28, 2010
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cellsAndreas Moosmann, Iris Bigalke, Johanna Tischer, et al.
Nature Communications|January 9, 2024
Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complexFabian Giehler, Michael S Ostertag, Thomas Sommermann, et al.
Cytotherapy|May 7, 2022
Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapyMaría Fernanda Lammoglia Cobo, Carlotta Welters, Leonie Rosenberger, et al.
Blood|August 15, 2002
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cellsAndreas Moosmann, Naeem Khan, Mark Cobbold, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Cell Reports Methods|June 24, 2025
Characterization of human CMV-specific CD8<sup>+</sup> T cells using multi-layer single-cell omicsIoanna Gemünd, Lorenzo Bonaguro, Matthias Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2016
Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cellsManuel Albanese, Takanobu Tagawa, Mickaël Bouvet, et al.
Journal of Translational Medicine|May 11, 2018
Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell graftsRegina Gary, Michael Aigner, Stephanie Moi, et al.
The Journal of Experimental Medicine|September 14, 2016
Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processingTakanobu Tagawa, Manuel Albanese, Mickaël Bouvet, et al.
European Journal of Immunology|May 26, 2005
HLA type-independent generation of antigen-specific T cells for adoptive immunotherapyMarkus H Hammer, Sonja Meyer, Gordon Brestrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2020
Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cellsM Zeeshan Chaudhry, Rosaely Casalegno-Garduno, Katarzyna M Sitnik, et al.
Blood|January 28, 2010
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cellsAndreas Moosmann, Iris Bigalke, Johanna Tischer, et al.
Nature Communications|January 9, 2024
Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complexFabian Giehler, Michael S Ostertag, Thomas Sommermann, et al.
Cytotherapy|May 7, 2022
Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapyMaría Fernanda Lammoglia Cobo, Carlotta Welters, Leonie Rosenberger, et al.
Blood|August 15, 2002
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cellsAndreas Moosmann, Naeem Khan, Mark Cobbold, et al.
Pageof 6